Work

Anticancer Tc9 cells: Long-lived tumor-killing T cells for adoptive therapy

Year: 2014

Type: article

Abstract: T-cell subset. These long-lived immune cells possess the capacity to acquire effector function and home to tumor tissues after adoptive transfer. IL-9 is indispensable for Tc9-mediated superior antitumor response. These findings are highly significant and crucial to achieve advances in T cell-based adoptive therapies.

Source: OncoImmunology

DOI: 10.4161/onci.28542

Authors: Yong Lu, Qiang Wang, Qing Yi

Institutions: Cleveland Clinic, Cleveland Clinic Lerner College of Medicine

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,913